The bulk drugs (API) segment contributed around 58 per cent to the company’s total turnover in Q3' FY 2019-20. The company’s expanding ... Feb 18
Consolidated Net Profit rises by 64% to Rs. 1,908.39 Mn. in Q3 FY 2019-20. Consolidated EBITDA rises by 1.2% to Rs. ... Feb 15